HMR (Hydroxytyrosol from Olive)

Hydroxytyrosol is a polyphenolic compound derived from olive oil that demonstrates potent antioxidant activity through scavenging free radicals and reducing oxidative stress. This bioactive compound modulates inflammatory pathways and has shown clinical benefits for joint health and body composition in human trials.

Origin & History

HMR (Hydroxytyrosol from Olive) is a branded form of hydroxytyrosol, a potent phenolic compound derived from olives (Olea europaea), extracted from olive leaves, fruits, or processing by-products like debittering water. It originates through hydrolysis of oleuropein and is extracted using methods such as resin adsorption, with some sources yielding up to 10.10% w/w HT richness.

Historical & Cultural Context

Hydroxytyrosol is inherently linked to the Mediterranean diet, where olives and olive oil have been dietary staples associated with reduced chronic disease incidence, as demonstrated in the PREDIMED study. While olives have been used in Mediterranean traditional medicine for their antioxidant and anti-inflammatory properties, HT-specific supplementation represents a modern application of this traditional knowledge.

Health Benefits

• Reduces joint pain in gonarthrosis patients, improving orthopedic scores after 4 weeks (RCT evidence, PMID: 23746949)
• Decreases breast density in women over 60 at cancer risk by 3.7% after 12 months (open-label trial, n=41, PMID: 39882028)
• Improves body composition and reduces fat mass with long-term supplementation (RCT evidence, PMC9003406)
• Enhances antioxidant status in overweight/prediabetic individuals (double-blind RCT, PMID: 40690822)
• Improves glucose/lipid profiles and modulates inflammatory gene expression at 15 mg/day for 3 weeks (RCT in healthy volunteers, PMC5569630)

How It Works

Hydroxytyrosol exerts its effects primarily through the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, upregulating antioxidant enzymes like superoxide dismutase and catalase. It inhibits pro-inflammatory cytokines including TNF-α and IL-1β while modulating cyclooxygenase and lipoxygenase enzymes. The compound also enhances nitric oxide bioavailability and protects cellular membranes from lipid peroxidation.

Scientific Research

Clinical evidence includes multiple RCTs demonstrating HT's effects on joint pain (PMID: 23746949), breast density reduction in cancer-risk women (n=41 completed, PMID: 39882028), and metabolic improvements in overweight individuals (PMID: 40690822). A meta-analysis supports cardiometabolic benefits from HT and related olive phenolics (PMID: 39828996), with doses ranging from 15-25 mg/day showing significant effects on body composition and antioxidant status.

Clinical Summary

A randomized controlled trial in gonarthrosis patients showed hydroxytyrosol significantly reduced joint pain and improved orthopedic scores after 4 weeks of supplementation. An open-label trial with 41 women over 60 demonstrated a 3.7% reduction in breast density after 12 months, suggesting potential cancer risk reduction benefits. Additional studies indicate improvements in body composition and fat mass reduction, though the evidence base remains limited with small sample sizes. Most clinical research has focused on short-term outcomes, requiring longer-term studies to establish sustained benefits.

Nutritional Profile

HMR (Hydroxytyrosol from Olive) is a purified polyphenolic bioactive compound, not a whole food, and therefore lacks conventional macronutrients, vitamins, or minerals in meaningful quantities. The primary bioactive is hydroxytyrosol (3,4-dihydroxyphenylethanol), a catechol-type phenol typically standardized to ≥99% purity in HMR extracts derived from olive mill wastewater or olive pulp. Typical supplemental doses range from 15–50 mg/day of hydroxytyrosol equivalent. Bioactive compound profile includes: hydroxytyrosol as the dominant phenol (>95% of active content), with trace amounts of tyrosol, oleuropein aglycone derivatives, and homovanillic acid as minor co-occurring compounds depending on extraction method. Hydroxytyrosol has exceptionally high oral bioavailability estimated at 60–99% in human studies, attributed to its low molecular weight (154.16 g/mol) and high aqueous solubility, with peak plasma concentrations (Tmax) reached within 30–60 minutes post-ingestion and urinary recovery of metabolites (hydroxytyrosol sulfate, homovanillic acid, homovanillyl alcohol) measurable within 2–4 hours. It carries no caloric load, fiber, protein, or fat content at supplemental doses. Antioxidant capacity is quantified at an ORAC value approximately 3x that of resveratrol per mole, with an IC50 for DPPH radical scavenging reported at ~1.2 µM in vitro.

Preparation & Dosage

Clinically studied doses range from 15-25 mg/day of standardized HT in enteric-coated capsules or extracts. Specific protocols include 15 mg/day (elaVida™) for 3 weeks for body composition, and 25 mg/day oral for 12 months for breast density reduction. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, Resveratrol, CoQ10, Quercetin, Alpha-Lipoic Acid

Safety & Interactions

Hydroxytyrosol is generally well-tolerated with minimal reported side effects in clinical trials. No significant drug interactions have been documented, though theoretical interactions may exist with anticoagulant medications due to potential effects on platelet aggregation. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data. Individuals with olive allergies should exercise caution, and those on blood pressure medications should monitor levels as hydroxytyrosol may have mild hypotensive effects.